Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAF
Dummer, Reinhard
Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAF [electronic resource] - The Lancet. Oncology 03 2020 - 358-372 p. digital
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1474-5488
10.1016/S1470-2045(20)30062-0 doi
Adolescent
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Double-Blind Method
Drug Resistance, Neoplasm--drug effects
Female
Follow-Up Studies
Humans
Imidazoles--administration & dosage
Male
Melanoma--drug therapy
Middle Aged
Mutation
Neoplasm Metastasis
Neoplasm Recurrence, Local--drug therapy
Oximes--administration & dosage
Prognosis
Proto-Oncogene Proteins B-raf--genetics
Pyridones--administration & dosage
Pyrimidinones--administration & dosage
Salvage Therapy
Skin Neoplasms--drug therapy
Survival Rate
Young Adult
Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAF [electronic resource] - The Lancet. Oncology 03 2020 - 358-372 p. digital
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1474-5488
10.1016/S1470-2045(20)30062-0 doi
Adolescent
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Double-Blind Method
Drug Resistance, Neoplasm--drug effects
Female
Follow-Up Studies
Humans
Imidazoles--administration & dosage
Male
Melanoma--drug therapy
Middle Aged
Mutation
Neoplasm Metastasis
Neoplasm Recurrence, Local--drug therapy
Oximes--administration & dosage
Prognosis
Proto-Oncogene Proteins B-raf--genetics
Pyridones--administration & dosage
Pyrimidinones--administration & dosage
Salvage Therapy
Skin Neoplasms--drug therapy
Survival Rate
Young Adult